Reference Material Conference

Conference Info

February 25-26, 2025
Virtual Conference

Info Coming Soon!

Brochure
Registration
Abstract Submission

US Bioassay Conference

Conference Info

March 24-26, 2025
Tucson, AZ, USA
Hybrid Conference

Brochure
Registration
Abstract Submission
Hotel Registration

Host Cell Protein Conference

Conference Info

May 28-30, 2025
Bled, Slovenia
Hybrid Conference

Brochure
Registration
Abstract Submission
Hotel Registration

EUR Bioassay Conference

Conference Info

24-26 September 2025
Rotterdam, Netherlands
Hybrid Conference

Brochure
Registration
Abstract Submission
Hotel Registration

BEBPA Updates

Sign up for BEBPA emails! We’re always sending out conference updates and other important information!


By submitting this form, you are consenting to receive marketing emails from: info@bebpa.com. You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact

Welcome to the BioPharmaceutical Emerging Best Practices Association (BEBPA)

BEBPA is a non-profit organization managed by and for the benefit of the biopharmaceutical scientific community. BEBPA provides an international forum for the presentation and discussion of scientific issues and problems encountered in the biopharmaceutical community. The aim of this open discussion is to promote development of innovative approaches and solutions thus facilitating safer and faster biopharmaceutical product development.

Smaller conferences will be held on various topics and a non-consensus white paper will be published delineating various approaches to solving these problems. The papers are not intended to be guidance documents, but rather strive to present the scientific community with a variety of approaches to potentially solve a common problem. Since the papers are not consensus documents, nor prescribe a preferred approach, publication can occur rapidly in open access journals and publicly available web pages and thus be part of the scientific discussion. Additionally, it is hoped that with the publication of potentially problem-solving approaches, the biopharmaceutical scientific community will accelerate the rate at which a future consensus best practice can be established.

BioPharmaceutical Emerging Best Practices Association (BEBPA)

We aim to foster publication of white papers and industry surveys which identify current practices, current technical hurdles and potential solutions relevant to the biopharmaceutical community – companies, regulators, clinicians. Identifying emerging issues early during development can often foster quicker, more efficient development for all firms.

Feedback from Past Attendees

Questions? Contact us today or call 206-651-4542.